Page last updated: 2024-08-21

triethylenephosphoramide and Cancer of Ovary

triethylenephosphoramide has been researched along with Cancer of Ovary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijnen, JH; Doodeman, VD; Ekhart, C; Huitema, AD; Rodenhuis, S; Smits, PH	1
Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM	1
Hagen, B; Neverdal, G; Nilsen, OG; Walstad, RA	1
Hagen, B	1

Trials

1 trial(s) available for triethylenephosphoramide and Cancer of Ovary

Article	Year
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin. Therapeutic drug monitoring, 2005, Volume: 27, Issue:6 Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide	2005

Article

Year

Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.

Therapeutic drug monitoring, 2005, Volume: 27, Issue:6

Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide

2005

Other Studies

3 other study(ies) available for triethylenephosphoramide and Cancer of Ovary

Article	Year
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa. British journal of clinical pharmacology, 2009, Volume: 67, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Carboplatin; Chromatography, High Pressure Liquid; Cohort Studies; Cyclophosphamide; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Thiotepa; Triethylenephosphoramide	2009
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alkylation; Female; Half-Life; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Thiotepa; Triethylenephosphoramide; Urine	1990
Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects. Cancer chemotherapy and pharmacology, 1991, Volume: 27, Issue:5 Topics: Aged; Aged, 80 and over; Bilirubin; Bone Marrow Diseases; Creatinine; Female; Humans; Leukocyte Count; Middle Aged; Ovarian Neoplasms; Platelet Count; Regression Analysis; Thiotepa; Triethylenephosphoramide	1991